Post-treatment, AD mice exhibited reduced dermatitis scores and improved pathological conditions, with a significant decrease in ROS levels in the lesional skin after 56 days
Some people taking semaglutide report mild itching or skin tingling, though these experiences are less frequent than gastrointestinal symptoms
Beyond primary care, the growth of digital and remote prescribing channels has broadened access to GLP-1 therapies significantly, reaching patients who may not easily access specialist weight management services through traditional routes
Both phases require monitoring and potentially different dose adjustments
These blockages can also cut off blood supply to the intestine, contributing to gangrene, or tissue death
[Abstract] The mice received daily subcutaneous injections of 10 nmol/kg of Retatrutide for 10 weeks